In vivo, 3F-NEB acts as a potent inhibitor of the dopamine transporter, exhibiting more than 100-fold selectivity over the serotonin transporter. Administration of 3 milligrams rapidly increased extracellular dopamine levels in the nucleus accumbens, of the rat. At the behavioural level, 3F-NEB caused a dose-dependent increase in motor activity at doses of 10–30 mg/kg, with the highest doses inducing anxiety-like effects.[1]
↑ 1.01.1"Neurochemical and behavioral evidence of high abuse liability of 3F-NEB, a novel synthetic cathinone". European Journal of Pharmacology1015. February 2026. doi:10.1016/j.ejphar.2026.178570. PMID41554370.
↑European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System. European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/396103. ISBN978-92-9497-737-3.